For Immediate Release
Chicago, IL- July 25, 2014 – Today, Zacks Investment Ideas feature highlights Features: Wal-Mart (WMT-Free Report), Johnson and Johnson (JNJ-Free Report) and Hewlett-Packard (HPQ-Free Report).
3D Printing Stocks See Big Interest
There are some people that say 3D printing is the stuff of science fiction. Others say limited applications and prohibitive costs make it a dream of the far reaching speculator. Lately, there has been signs of interest mega capitalization companies that not only give credibility to these stocks, it might make it less of a speculative play.
About a year ago a video on YouTube went viral. It was the first 3D Printed Metal Gun. We have seen the plastic guns and replicas of an AK-47, but the metal gun was the first of its kind. This more or less took the sector from being a "toy maker" to a "supply chain component."
A simple search of "3d printed" on YouTube delivers more than 500,000 results, so it’s fair to say that this craze might just be getting started.
Interest From Big Parties
There have been several recent reports about multi-billion dollar companies partnering / buying / utilizing the 3D printing technologies to stay ahead of the curve in their own industry.
At the Code Conference in Rancho Palos Verdes, the CEO of Wal-Mart (WMT-Free Report) noted that he was interested in the space. The obvious use for WMT would be to print replacement parts for broken or damaged items to lower return costs. Installing a printer in each WMT would allow customers to print their own parts as well, and that would end up driving foot traffic into the stores.
A Circulated Story
A radical story broke a few weeks and a great video was published by the University of Pennsylvania. The headline of 3D printed blood vessels sent shares of Organovo Holdings up by more than 4.4% on July 1.
Today there was further confirmation that this story is not just pie in the sky. Janssen Research and Development LCC (a division of Johnson and Johnson (JNJ-Free Report) entered into an agreement with Organovo to evaluate the use of 3D bio=-printed tissue in a drug discovery setting, outside of the Company’s work in 3D liver tissue for toxicity testing.
This sent shares of ONVO soaring more than 20% before the market opened, but my mid-day shares have fallen back to a mere 8% gain.
The partnership with a JNJ gives credibility to a part of the 3D printing segment that was seemed probably the most outrageous by the naysayers. Given that there haven't been any results released, just the fact that JNJ is taking it very seriously shows that there is more here than just a good story.
The Next Bubble Jet?
Maybe that headline should annotated with some "tongue in cheek" indicator. 3D printers at a cost of nearly $500,000 will take a long time before they are as ubiquitous as the Bubble Jet printer was in the 90's, but it will be one day.
Hewlett-Packard (HPQ-Free Report) is often discussed as the next company to get into the 3D printing game. As a leader in the printing space, it only seems logical that they address the high end of the market.
Predictions have been made that the company will enter the market this year or next, but it appears as though that sort of move is inevitable. When a major tech firm throws its hat in the ring, the naysayers of this technology will likely change their tune.
Zacks.com is a property of Zacks Investment Research, Inc., which was formed in 1978. The later formation of the Zacks Rank, a proprietary stock picking system; continues to outperform the market by nearly a 3 to 1 margin. The best way to unlock the profitable stock recommendations and market insights of Zacks Investment Research is through our free daily email newsletter; Profit from the Pros. In short, it's your steady flow of Profitable ideas GUARANTEED to be worth your time! Click here for your free subscription to Profit from the Pros.
Get the full Report on WMT – FREE
Get the full Report on JNJ – FREE
Get the full Report on HPQ – FREE
Follow us on Twitter: http://twitter.com/ZacksResearch
Join us on Facebook: http://www.facebook.com/ZacksInvestmentResearch
Zacks Investment Research is under common control with affiliated entities (including a broker-dealer and an investment adviser), which may engage in transactions involving the foregoing securities for the clients of such affiliates.
Zacks Investment Research
800-767-3771 ext. 9339
Past performance is no guarantee of future results. Inherent in any investment is the potential for loss. This material is being provided for informational purposes only and nothing herein constitutes investment, legal, accounting or tax advice, or a recommendation to buy, sell or hold a security. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. It should not be assumed that any investments in securities, companies, sectors or markets identified and described were or will be profitable. All information is current as of the date of herein and is subject to change without notice. Any views or opinions expressed may not reflect those of the firm as a whole. Zacks Investment Research does not engage in investment banking, market making or asset management activities of any securities. These returns are from hypothetical portfolios consisting of stocks with Zacks Rank = 1 that were rebalanced monthly with zero transaction costs. These are not the returns of actual portfolios of stocks. The S&P 500 is an unmanaged index. Visit http://www.zacks.com/performance for information about the performance numbers displayed in this press release.